Geographic Information Systems Mapping of Diabetic Retinopathy in an Ocular Telemedicine Network

JAMA Ophthalmology
Pooja D JaniSeema Garg

Abstract

Minimal information exists on the use of geographic information systems mapping for visualizing access barriers to eye care for patients with diabetes. To use geographic information systems mapping techniques to visualize (1) the locations of patients participating in the North Carolina Diabetic Retinopathy Telemedicine Network, (2) the locations of primary care clinicians and ophthalmologists across the state, and (3) the travel times associated with traveling to the 5 primary care clinics in our study. Cross-sectional study conducted from January 6, 2014, to November 1, 2015, at 5 Area Health Education Center primary care clinics that serve rural and underserved populations in North Carolina. In total, 1787 patients with diabetes received retinal screening photographs with remote expert interpretation to determine the presence and severity of diabetic retinopathy. Participants included patients 18 years or older with type 1 or type 2 diabetes who presented to these 5 clinics for their routine diabetes care. Development of qualitative maps illustrating the density of patients with diabetes and their distribution around the 5 North Carolina Diabetic Retinopathy Telemedicine Network sites by zip code and the density of ophthalmo...Continue Reading

Citations

Aug 29, 2018·JAAPA : Official Journal of the American Academy of Physician Assistants·Joanne DeTore, Denise Rizzolo
Nov 28, 2018·Telemedicine Journal and E-health : the Official Journal of the American Telemedicine Association·Xinxiao GaoJay Federman
Jan 27, 2019·Diabetes Care·Stephen R BenoitJinan B Saaddine
Mar 31, 2020·Acta Diabetologica·Paolo LanzettaUNKNOWN Vision Academy
Feb 19, 2021·Telemedicine Journal and E-health : the Official Journal of the American Telemedicine Association·Christopher J BradyBrian Y Kim

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.